| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |